2Leveque FG,Montgomery M,Potter D,et al.A double-blind,placebo-controlled,dosetitration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients[J].J Clin Oncol, 1993,11 (6): 1124-1131.
2Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy [J], Respir Med, 1998,92:6092.
3Tersmoto S, Suzuki M, Ohga E,et al. Effects of ambroxol on spontaneous or stimulated generation of reaotive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary diseases [ J ]. Pharmacology,1999,59 : 135-141.
4Pfeifer S,Zissel G, Kienast K, et al. Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol [ J ].Eur J Med Res, 1997,2:129-132.
5Pairet M, Engelmann P, Yon Nicolai H, et al, Ambroxol improves the broncho-spasmolytic activity of clenbuterol in the guinea pig[J]. J Pharm Pharmacol, 1997,49 : 184-186.
6W Couet, J Girault. Steady-state bioavailability and pharmacokinetics of ambroxol and clenbuterol administered alone and combined in a new oral formulation[J]. Intern J Clin Pharmacol,Therapy Toxicol, Vol. 27 No. 9-1989 (467-472).
7Michel P, Peter E. Ambroxol improves the broncho-spasmolytic activity of clenbuterol in the guinea-pig[ J]. J Pharm Pharmacol,1997,49,184-186.
